France) for providing PrV glycoproteins and virulent PrV and Dr F, Lefevre ,
) for their excellent technical assistance. This study was supported by grant QLK2-CT- 496 2002-01204, FMDnaVacc project ,
Foot-And-Mouth Disease, Annual Review of Microbiology, vol.22, issue.1, pp.201-244, 1968. ,
DOI : 10.1146/annurev.mi.22.100168.001221
Immune response characteristics following emergency 563 vaccination of pigs against foot-and-mouth disease, Vaccine, vol.23, pp.1037-1047, 2005. ,
Developments in foot-and-mouth disease vaccines, Vaccine, vol.9, issue.2, pp.75-88, 1991. ,
DOI : 10.1016/0264-410X(91)90261-4
Porcine B-cell activating factor promotes anti-FMDV antibodies in vitro but not in vivo after DNA vaccination of pigs, Veterinary Immunology and Immunopathology, vol.120, issue.3-4, pp.115-123, 2007. ,
DOI : 10.1016/j.vetimm.2007.06.021
Interspecies major histocompatibility complex- 571 restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4, J. 572 Virol, vol.74, pp.4902-4907, 2000. ,
DNA vaccines expressing B and T cell epitopes can 575 protect mice from FMDV infection in the absence of specific humoral responses, Vaccine, vol.24, pp.576-3889, 2006. ,
578 Induction of a protective response in swine vaccinated with DNA encoding foot-and- 579 mouth disease virus empty capsid proteins and the 3D RNA polymerase, J. Gen. Virol, vol.580, issue.82, pp.1713-1724, 2001. ,
Immunogenicity of plasmids encoding T and B 583 cell epitopes of foot-and-mouth disease virus (FMDV) in swine, Vaccine, vol.21, pp.4261-584, 2003. ,
Extract from Agaricus blazei Murill can enhance immune responses elicited by DNA vaccine against foot-and-mouth disease, Veterinary Immunology and Immunopathology, vol.109, issue.1-2, pp.177-182, 2006. ,
DOI : 10.1016/j.vetimm.2005.08.028
Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines, Vaccine, vol.21, issue.13-14, pp.1336-1347, 2003. ,
DOI : 10.1016/S0264-410X(02)00691-6
CpG motif in ATCGAT hexamer improves DNA-vaccine efficiency against lethal Pseudorabies virus infection in pigs, Vaccine, vol.23, issue.36, pp.4532-4540, 2005. ,
DOI : 10.1016/j.vaccine.2005.03.046
Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins, Vaccine, vol.23, issue.26, pp.3483-3491, 2005. ,
DOI : 10.1016/j.vaccine.2004.10.050
Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor, Vaccine, vol.25, issue.49, pp.8209-8219, 2007. ,
DOI : 10.1016/j.vaccine.2007.09.062
Induction of porcine cytokine mRNA expression after DNA immunization and 603 pseudorabies virus infection, J. Interferon Cytokine Res, vol.602, issue.20, pp.885-890, 2000. ,
Immunization of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus, Virus Genes, vol.72, issue.2, pp.347-357, 2007. ,
DOI : 10.1007/s11262-007-0105-0
IL-4 is required to generate and sustain in vivo IgE responses, J. 609 Immunol, vol.141, pp.2335-2341, 1988. ,
Immune response to uncoupled peptides of foot-and-mouth disease virus, Immunology, vol.61, pp.612-613, 1987. ,
Immune and protective abilities of ubiquitinated and non-ubiquitinated pseudorabies 615 virus glycoproteins, Acta Virol, vol.51, pp.614-649, 2007. ,
Development of novel strategies to control foot-and-mouth disease: Marker vaccines and antivirals, Biologicals, vol.33, issue.4, pp.227-234, 2005. ,
DOI : 10.1016/j.biologicals.2005.08.009
Foot-and-Mouth Disease, Clinical Microbiology Reviews, vol.17, issue.2, pp.465-493, 2004. ,
DOI : 10.1128/CMR.17.2.465-493.2004
Crystal Structure of Glycoprotein B from Herpes Simplex Virus 1, Science, vol.313, issue.5784, pp.217-621, 2006. ,
DOI : 10.1126/science.1126548
Engineering Glycoprotein B of Bovine Herpesvirus 1 To Function as Transporter for Secreted Proteins: a New Protein Expression Approach, Journal of Virology, vol.79, issue.2, pp.791-799, 2005. ,
DOI : 10.1128/JVI.79.2.791-799.2005
Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK, Nature, vol.71, issue.5832, pp.479-480, 1981. ,
DOI : 10.1038/293479a0
Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capsid from serotype O, Vaccine, vol.24, issue.21, pp.4602-4606, 2006. ,
DOI : 10.1016/j.vaccine.2005.08.032
Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost, Vaccine, vol.26, issue.21, pp.2647-2656, 2008. ,
DOI : 10.1016/j.vaccine.2008.01.037
Immune responses generated by 635 Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus, Vaccine, vol.25, pp.636-902, 2007. ,
A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus, Journal of Virological Methods, vol.97, issue.1-2, pp.33-48, 2001. ,
DOI : 10.1016/S0166-0934(01)00333-0
On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other, The Annals of Mathematical Statistics, vol.18, issue.1, pp.50-60, 1947. ,
DOI : 10.1214/aoms/1177730491
Effects of Truncation of the Carboxy Terminus of Pseudorabies Virus Glycoprotein B on Infectivity, OIE Manual of Standards for diagnostics tests and vaccines, pp.7137-7145, 2000. ,
DOI : 10.1128/JVI.74.15.7137-7145.2000
Evolutionary analysis of the picornavirus family, Journal of Molecular Evolution, vol.9, issue.4, pp.362-371, 1995. ,
DOI : 10.1007/BF00164022
Foot-and-mouth disease virus: biology and prospects for disease control, Microbes and Infection, vol.4, issue.11, pp.1183-1192, 2002. ,
DOI : 10.1016/S1286-4579(02)01644-1
Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission, Vaccine, vol.16, issue.7, pp.746-754, 1998. ,
DOI : 10.1016/S0264-410X(97)86180-4
Foot-and-mouth disease virus:
a long known virus, but a current threat, Veterinary Research, vol.32, issue.1, pp.1-30, 2001. ,
DOI : 10.1051/vetres:2001106
URL : https://hal.archives-ouvertes.fr/hal-00902685
The potency testing of pseudorabies vaccines in pigs. A proposal for a quantitative criterion and a minimum requirement, Journal of Biological Standardization, vol.17, issue.1, pp.17-27, 1989. ,
DOI : 10.1016/0092-1157(89)90024-3
A DNA vaccine coding for glycoprotein B of 666 pseudorabies virus induces cell-mediated immunity in pigs and reduces virus excretion 667 early after infection, Vet. Immunol. Immunopathol, vol.74, pp.121-136, 2000. ,
A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2, Vaccine, vol.20, issue.21-22, pp.2641-2647, 2002. ,
DOI : 10.1016/S0264-410X(02)00212-8
T cell cytokines and disease prevention, Veterinary Immunology and Immunopathology, vol.54, issue.1-4, pp.33-44, 1996. ,
DOI : 10.1016/S0165-2427(96)05711-X
Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants, Antiviral Research, vol.76, issue.1, pp.11-20, 2007. ,
DOI : 10.1016/j.antiviral.2007.04.002
678 Distribution of B-cell epitopes on the pseudorabies virus glycoprotein B, J. Gen. Virol, vol.679, issue.80, pp.537-541, 1999. ,
Glycoprotein B of Aujeszky's disease virus: topographical epitope mapping and epitope-specific antibody response, Research in Virology, vol.149, issue.1, pp.29-41 ,
DOI : 10.1016/S0923-2516(97)86898-7
Immune response in mice inoculated with plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus, Vaccine, vol.21, issue.32, pp.4704-4707, 2003. ,
DOI : 10.1016/S0264-410X(03)00519-X